DUSP4 and hepatocellular carcinoma: Furthermore, DUSP4 deficiency inhibited Lenvatinib-induced apoptosis, whereas the overexpression of DUSP4 sensitized HCC cells to Lenvatinib-induced apoptosis (Figure 3F and G).